Advertisement

Unified Airway Disease

A Contemporary Review and Introduction
Published:October 17, 2022DOI:https://doi.org/10.1016/j.otc.2022.09.001

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Otolaryngologic Clinics of North America
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Genuneit J.
        • Seibold A.M.
        • Apfelbacher C.J.
        • et al.
        Overview of systematic reviews in allergy epidemiology.
        Allergy. 2017; 7: 12https://doi.org/10.1186/s13601-017-0146-y
        • Hellings P.W.
        • Verhoeven E.
        • Fokkens W.J.
        State-of-the-art overview on biological treatment for CRSwNP.
        Rhinology. 2021; 59: 151-163
        • Agache I.
        • Beltran J.
        • Akdis C.
        • et al.
        Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma.
        Allergy. 2020; 75: 1023-1042
        • Shamji M.H.
        • Palmer E.
        • Layhadi J.A.
        • et al.
        Biological treatment in allergic disease.
        Allergy. 2021; 76: 2934-2937
        • Desrosiers M.
        • Mannent L.P.
        • Amin N.
        • et al.
        Dupilumab reduces systemic corticosteroid use and sinonasal surgery rate in CRSwNP.
        Rhinology. 2021; 59: 301-311
        • Leynaert B.
        • Neukirch C.
        • Liard R.
        • et al.
        Quality of life in allergic rhinitis and asthma. A population-based study of young adults.
        Am J Respir Crit Care Med. 2000; 162: 1391-1396
        • Fokkens W.J.
        • Lund V.J.
        • Hopkins C.
        • et al.
        European position paper on rhinosinusitis and nasal polyps 2020.
        Rhinology. 2020; 58: 1-464
        • Linneberg A.
        • Dam Petersen K.
        • Hahn-Pedersen J.
        • et al.
        Burden of allergic respiratory disease: a systematic review.
        Clin Mol Allergy. 2016; 14: 12
        • Khan A.
        • Huynh T.M.T.
        • Vandeplas G.
        • et al.
        The GALEN rhinosinusitis cohort: chronic rhinosinusitis with nasal polyps affects health-related quality of life.
        Rhinology. 2019; 57: 343-351
        • Hopkins C.
        • Conlon S.
        • Chavda S.
        • et al.
        Investigating the secondary care system burden of CRSwNP in sinus surgery patients with clinically relevant comorbidities using the HES database.
        Rhinology. 2022; 60: 252-260
        • Akdis C.A.
        • Bachert C.
        • Cingi C.
        • et al.
        Endotypes and phenotypes of chronic rhinosinusitis: a PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology.
        J Allergy Clin Immunol. 2013; 131: 1479-1490
        • Asano K.
        • Ueki S.
        • Tamari M.
        • et al.
        Adult-onset eosinophilic airway diseases.
        Allergy. 2020; 75: 3087-3099
        • Kanda A.
        • Kobayashi Y.
        • Asako M.
        • et al.
        Regulation of interaction between the upper and lower airways in united airway disease.
        Med Sci (Basel). 2019; 7: 27https://doi.org/10.3390/medsci7020027
        • Backaert W.
        • Steelant B.
        • Jorissen M.
        • et al.
        Self-reported nasal hyperreactivity is common in all chronic upper airway inflammatory phenotypes and not related to general well-being.
        Allergy. 2021; 76: 3806-3809
        • Feijen J.
        • Seys S.F.
        • Steelant B.
        • et al.
        Prevalence and triggers of self-reported nasal hyperreactivity in adults with asthma.
        World Allergy Organ J. 2020; 13: 100132
        • Doulaptsi M.
        • Steelant B.
        • Prokopakis E.
        • et al.
        Prevalence and impact of nasal hyperreactivity in chronic rhinosinusitis.
        Allergy. 2020; 75: 1768-1771
        • Avdeeva K.S.
        • Fokkens W.J.
        • Reitsma S.
        Towards a new epidemiological definition of chronic rhinitis: prevalence of nasal complaints in the general population.
        Rhinology. 2021; 59: 258-266
        • Tomassen P.
        • Vandeplas G.
        • Van Zele T.
        • et al.
        Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers.
        J Allergy Clin Immunol. 2016; 137 (e4): 1449-1456
        • Stevens W.W.
        • Peters A.T.
        • Tan B.K.
        • et al.
        Associations between inflammatory endotypes and clinical presentations in chronic rhinosinusitis.
        J Allergy Clin Immunol Pract. 2019; 7: 2812-2820.e3
        • Agache I.
        • Sugita K.
        • Morita H.
        • et al.
        The Complex type 2 endotype in allergy and asthma: from laboratory to bedside.
        Curr Allergy Asthma Rep. 2015; 15: 29
        • Papadopoulos N.G.
        • Bernstein J.A.
        • Demoly P.
        • et al.
        Phenotypes and endotypes of rhinitis and their impact on management: a PRACTALL report.
        Allergy. 2015; 70: 474-494
        • Viiu B.
        • Christer J.
        • Fredrik S.
        • et al.
        Asthma in combination with rhinitis and eczema is associated with a higher degree of type-2 inflammation and symptom burden than asthma alone.
        Allergy. 2021; 76: 3827-3829
        • Hong H.
        • Liao S.
        • Chen F.
        • et al.
        Role of IL-25, IL-33, and TSLP in triggering united airway diseases toward type 2 inflammation.
        Allergy. 2020; 75: 2794-2804
        • Kato A.
        • Peters A.T.
        • Stevens W.W.
        • et al.
        Endotypes of chronic rhinosinusitis: Relationships to disease phenotypes, pathogenesis, clinical findings, and treatment approaches.
        Allergy. 2022; 77: 812-826
        • Cho H.J.
        • Ha J.G.
        • Lee S.N.
        • et al.
        Differences and similarities between the upper and lower airway: focusing on innate immunity.
        Rhinology. 2021; 59: 441-450
        • Steelant B.
        • Seys S.F.
        • Boeckxstaens G.
        • et al.
        Restoring airway epithelial barrier dysfunction: a new therapeutic challenge in allergic airway disease.
        Rhinology. 2016; 54: 195-205
        • Scadding G.K.
        • Scadding G.W.
        Innate and adaptive immunity: ILC2 and Th2 Cells in upper and lower airway allergic diseases.
        J Allergy Clin Immunol Pract. 2021; 9: 1851-1857
        • van der Ploeg E.K.
        • Golebski K.
        • van Nimwegen M.
        • et al.
        Steroid-resistant human inflammatory ILC2s are marked by CD45RO and elevated in type 2 respiratory diseases.
        Sci Immunol. 2021; 6: eabd3489
        • Stamataki S.
        • Papadopoulos N.G.
        • Lakoumentas J.
        • et al.
        Nasal epithelium: new insights and differences of the cytokine profile between normal subjects and subjects with allergic rhinitis.
        Rhinology Online. 2021; 4: 223-232
        • Bashir M.E.
        • Ward J.M.
        • Cummings M.
        • et al.
        Dual function of novel pollen coat (surface) proteins: IgE-binding capacity and proteolytic activity disrupting the airway epithelial barrier.
        PLoS One. 2013; 8: e53337
        • Steelant B.
        • Farre R.
        • Wawrzyniak P.
        • et al.
        Impaired barrier function in patients with house dust mite-induced allergic rhinitis is accompanied by decreased occludin and zonula occludens-1 expression.
        J Allergy Clin Immunol. 2016; 137: 1043-1053.e1-5
        • Hellings P.W.
        • Steelant B.
        Epithelial barriers in allergy and asthma.
        J Allergy Clin Immunol. 2020; 145: 1499-1509
        • Tuli J.F.
        • Ramezanpour M.
        • Cooksley C.
        • et al.
        Association between mucosal barrier disruption by Pseudomonas aeruginosa exoproteins and asthma in patients with chronic rhinosinusitis.
        Allergy. 2021; 76: 3459-3469
        • Kao S.S.
        • Ramezanpour M.
        • Bassiouni A.
        • et al.
        Barrier disruptive effects of mucus isolated from chronic rhinosinusitis patients.
        Allergy. 2020; 75: 200-203
        • van Tongeren J.
        • Golebski K.
        • Van Egmond D.
        • et al.
        Synergy between TLR-2 and TLR-3 signaling in primary human nasal epithelial cells.
        Immunobiology. 2015; 220: 445-451
        • Radman M.
        • Golshiri A.
        • Shamsizadeh A.
        • et al.
        Toll-like receptor 4 plays significant roles during allergic rhinitis.
        Allergologia et Immunopathologia. 2015; 43: 416-420
        • van Tongeren J.
        • Roschmann K.I.
        • Reinartz S.M.
        • et al.
        Expression profiling and functional analysis of Toll-like receptors in primary healthy human nasal epithelial cells shows no correlation and a refractory LPS response.
        Clin Translational Allergy. 2015; 5: 42
        • Vroling A.B.
        • Jonker M.J.
        • Luiten S.
        • et al.
        Primary nasal epithelium exposed to house dust mite extract shows activated expression in allergic individuals.
        Am J Respir Cell Mol Biol. 2008; 38: 293-299
        • Golebski K.
        • van Egmond D.
        • de Groot E.J.
        • et al.
        EGR-1 and DUSP-1 are important negative regulators of pro-allergic responses in airway epithelium.
        Mol Immunol. 2015; 65: 43-50
        • Mjosberg J.M.
        • Trifari S.
        • Crellin N.K.
        • et al.
        Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161.
        Nat Immunol. 2011; 12: 1055-1062
        • Kortekaas Krohn I.
        • Shikhagaie M.M.
        • Golebski K.
        • et al.
        Emerging roles of innate lymphoid cells in inflammatory diseases: Clinical implications.
        Allergy. 2018; 73: 837-850
        • Karta M.R.
        • Broide D.H.
        • Doherty T.A.
        Insights into group 2 innate lymphoid cells in human airway disease.
        Curr Allergy Asthma Rep. 2016; 16: 8
        • Braunstahl G.J.
        • Fokkens W.
        Nasal involvement in allergic asthma.
        Allergy. 2003; 58: 1235-1243
        • Izuhara Y.
        • Matsumoto H.
        • Nagasaki T.
        • et al.
        Mouth breathing, another risk factor for asthma: the Nagahama Study.
        Allergy. 2016; 71: 1031-1036
        • Braunstahl G.J.
        United airways concept: what does it teach us about systemic inflammation in airways disease?.
        Proc Am Thorac Soc. 2009; 6: 652-654
        • Rimmer J.
        • Hellgren J.
        • Harvey R.J.
        Simulated postnasal mucus fails to reproduce the symptoms of postnasal drip in rhinitics but only in healthy subjects.
        Rhinology. 2015; 53: 129-134
        • Braunstahl G.J.
        • Kleinjan A.
        • Overbeek S.E.
        • et al.
        Segmental bronchial provocation induces nasal inflammation in allergic rhinitis patients.
        Am J Respir Crit Care Med. 2000; 161: 2051-2057
        • Braunstahl G.J.
        • Overbeek S.E.
        • Fokkens W.J.
        • et al.
        Segmental bronchoprovocation in allergic rhinitis patients affects mast cell and basophil numbers in nasal and bronchial mucosa.
        Am J Respir Crit Care Med. 2001; 164: 858-865
        • Braunstahl G.J.
        • Overbeek S.E.
        • Kleinjan A.
        • et al.
        Nasal allergen provocation induces adhesion molecule expression and tissue eosinophilia in upper and lower airways.
        J Allergy Clin Immunol. 2001; 107: 469-476
        • Allakhverdi Z.
        • Comeau M.R.
        • Smith D.E.
        • et al.
        CD34+ hemopoietic progenitor cells are potent effectors of allergic inflammation.
        J Allergy Clin Immunol. 2009; 123: 472-478
        • Sergejeva S.
        • Malmhall C.
        • Lotvall J.
        • et al.
        Increased number of CD34+ cells in nasal mucosa of allergic rhinitis patients: inhibition by a local corticosteroid.
        Clin Exp Allergy. 2005; 35: 34-38
        • de Groot J.C.
        • Amelink M.
        • de Nijs S.B.
        • et al.
        Risk factors for frequent severe exacerbations in late-onset eosinophilic asthma.
        Am J Respir Crit Care Med. 2015; 192: 899-902
        • Bachert C.
        • Humbert M.
        • Hanania N.A.
        • et al.
        Staphylococcus aureus and its IgE-inducing enterotoxins in asthma: current knowledge.
        Eur Respir J. 2020; 55: 1901592
        • Breiteneder H.
        • Peng Y.Q.
        • Agache I.
        • et al.
        Biomarkers for diagnosis and prediction of therapy responses in allergic diseases and asthma.
        Allergy. 2020; 75: 3039-3068
        • Ogulur I.
        • Pat Y.
        • Ardicli O.
        • et al.
        Advances and highlights in biomarkers of allergic diseases.
        Allergy. 2021; 76: 3659-3686
        • Ambrosino P.
        • Molino A.
        • Spedicato G.A.
        • et al.
        Nasal nitric oxide in chronic rhinosinusitis with or without nasal polyps: a systematic review with meta-analysis.
        J Clin Med. 2020; 9: 200
        • Rimmer J.
        • Hellings P.
        • Lund V.J.
        • et al.
        European position paper on diagnostic tools in rhinology.
        Rhinology. 2019; 57: 1-41
        • Reddel H.K.
        • Bacharier L.B.
        • Bateman E.D.
        • et al.
        Global initiative for asthma strategy 2021: executive summary and rationale for key changes.
        Eur Respir J. 2022; 59: 2102730
        • Lohia S.
        • Schlosser R.J.
        • Soler Z.M.
        Impact of intranasal corticosteroids on asthma outcomes in allergic rhinitis: a meta-analysis.
        Allergy. 2013; 68: 569-579
        • Farraia M.
        • Paciência I.
        • Castro Mendes F.
        • et al.
        Allergen immunotherapy for asthma prevention: A systematic review and meta-analysis of randomized and non-randomized controlled studies.
        Allergy. 2022; 77: 1719-1735
        • Vashishta R.
        • Soler Z.M.
        • Nguyen S.A.
        • et al.
        A systematic review and meta-analysis of asthma outcomes following endoscopic sinus surgery for chronic rhinosinusitis.
        Int Forum Allergy Rhinology. 2013; 3: 788-794
        • Cao Y.
        • Hong H.
        • Sun Y.
        • et al.
        The effects of endoscopic sinus surgery on pulmonary function in chronic rhinosinusitis patients with asthma: a systematic review and meta-analysis.
        Eur Arch Otorhinolaryngol. 2019; 276: 1405-1411
        • Hopkins C.
        • Rimmer J.
        • Lund V.J.
        Does time to endoscopic sinus surgery impact outcomes in Chronic Rhinosinusitis? Prospective findings from the National Comparative Audit of Surgery for Nasal Polyposis and Chronic Rhinosinusitis.
        Rhinology. 2015; 53: 10-17
        • Dixon A.E.
        • Castro M.
        • Cohen R.I.
        • et al.
        Efficacy of nasal mometasone for the treatment of chronic sinonasal disease in patients with inadequately controlled asthma.
        J Allergy Clin Immunol. 2015; 135: 701-709.e5
        • Agache I.
        • Song Y.
        • Alonso-Coello P.
        • et al.
        Efficacy and safety of treatment with biologicals for severe chronic rhinosinusitis with nasal polyps: a systematic review for the EAACI guidelines.
        Allergy. 2021; 76: 2337-2353
        • Maspero J.F.
        • FitzGerald J.M.
        • Pavord I.D.
        • et al.
        Dupilumab efficacy in adolescents with uncontrolled, moderate-to-severe asthma: LIBERTY ASTHMA QUEST.
        Allergy. 2021; 76: 2621-2624
        • Mullol J.
        • Laidlaw T.M.
        • Bachert C.
        • et al.
        Efficacy and safety of dupilumab in patients with uncontrolled severe chronic rhinosinusitis with nasal polyps and a clinical diagnosis of NSAID-ERD: Results from two randomized placebo-controlled phase 3 trials.
        Allergy. 2022; 77: 1231-1244
        • van der Lans R.J.L.
        • Fokkens W.J.
        • Adriaensen G.
        • et al.
        Real-life observational cohort verifies high efficacy of dupilumab for chronic rhinosinusitis with nasal polyps.
        Allergy. 2022; 77: 670-674
        • Hox V.
        • Lourijsen E.
        • Jordens A.
        • et al.
        Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis: an EAACI position paper.
        Clin Translational Allergy. 2020; 10: 1